In addition, SMAD2 and SMAD3 knockout augmented the production of inflammatory factor (TNFα and IL-6) [51], while SIRT2-mediated NLRP3 deacetylation protects against inflammation [22], indicating SIRT2 may be a more attractive target to improving renal fibrosis. Here, SMAD3 is linked to renal fibrosis.